Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,330 | 109,282 | 77,883 | 30,954 | 79,421 |
| Marketable Securities | 84,147 | 46,035 | 43,520 | 47,425 | 52,540 |
| Receivables | 1,313 | 899 | 1,667 | 1,298 | 1,265 |
| TOTAL | $172,698 | $160,661 | $126,536 | $83,466 | $137,341 |
| Non-Current Assets | |||||
| PPE Net | 5,664 | 5,983 | 6,352 | 6,779 | 6,584 |
| Investments And Advances | 56,318 | 35,688 | 30,534 | 42,906 | 0 |
| Other Non-Current Assets | 2,197 | 2,153 | 2,174 | 2,225 | 2,315 |
| TOTAL | $64,179 | $43,824 | $39,060 | $51,910 | $8,899 |
| Total Assets | $236,877 | $204,485 | $165,596 | $135,376 | $146,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,715 | 10,838 | 9,727 | 8,352 | 6,063 |
| TOTAL | $32,409 | $11,221 | $10,113 | $8,841 | $6,693 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,255 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 23,038 | 23,825 | 22,988 | 25,706 | 25,398 |
| TOTAL | $38,623 | $23,825 | $25,343 | $25,706 | $25,398 |
| Total Liabilities | $71,032 | $35,046 | $35,456 | $34,547 | $32,091 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 148,728 | 148,642 | 135,269 | 99,161 | 96,388 |
| Common Shares | 1,298,212 | 1,286,636 | 1,065,710 | 1,017,416 | 1,013,118 |
| Retained earnings | -1,150,112 | -1,134,347 | -1,112,452 | -1,088,207 | -1,065,554 |
| Other shareholders' equity | -49,406 | -48,335 | -48,187 | -48,199 | -48,168 |
| TOTAL | $165,845 | $169,439 | $130,140 | $100,829 | $114,149 |
| Total Liabilities And Equity | $236,877 | $204,485 | $165,596 | $135,376 | $146,240 |